phacoemulsification
Otherone group with BSS at room temperature and the other group with cold BSS
NCT Number: NCT06904560
patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs
Trial opening soon.
Get Notified40 year–80 year
All sexes
Interventional
Not applicable
patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients with corneal diseases patients less than 40 patients with previous eye surgery
one group with BSS at room temperature and the other group with cold BSS
Time frame: 3 months
Time frame: 3 months
incidence of anterior segment inflammation including conjunctival hypremia or corneal edema
Contact information is provided by the study sponsor or research team.
Sohag University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07149740
Corneal Diseases, Eye Diseases
Anaheim, California, United States
View Trial DetailsNCT06636708
Corneal Diseases, Effectiveness of Microdrops
New York, United States
View Trial DetailsNCT07024719
Corneal Diseases, Eye Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07132437
Corneal Diseases, Eye Diseases
Beijing, China
View Trial Details